![]() | ||
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
| EXHIBIT INDEX | ||||||||
| Exhibit No. | Description | |||||||
| 99.1 | ||||||||
| 99.2 | ||||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
| ENTEGRIS, INC. | ||||||||
| Dated: February 1, 2022 | By: | /s/ Gregory B. Graves | ||||||
| Name: | Gregory B. Graves | |||||||
| Title: | Executive Vice President and Chief Financial Officer | |||||||
![]() | PRESS RELEASE Bill Seymour VP of Investor Relations T + 1 952 556 1844 | |||||||||||||
| GAAP Results | December 31, 2021 | December 31, 2020 | October 2, 2021 | ||||||||
| Net sales | $635,204 | $517,594 | $579,493 | ||||||||
| Operating income | $159,544 | $113,228 | $139,357 | ||||||||
| Operating margin - as a % of net sales | 25.1 | % | 21.9 | % | 24.0 | % | |||||
| Net income | $118,219 | $86,624 | $117,461 | ||||||||
| Diluted earnings per common share | $0.87 | $0.63 | $0.86 | ||||||||
| Non-GAAP Results | |||||||||||
| Non-GAAP adjusted operating income | $176,770 | $126,945 | $152,696 | ||||||||
| Non-GAAP adjusted operating margin - as a % of net sales | 27.8 | % | 24.5 | % | 26.3 | % | |||||
| Non-GAAP net income | $131,783 | $97,123 | $125,383 | ||||||||
| Diluted non-GAAP earnings per common share | $0.96 | $0.71 | $0.92 | ||||||||
| Three months ended | ||||||||||||||
| December 31, 2021 | December 31, 2020 | October 2, 2021 | ||||||||||||
| Net sales | $635,204 | $517,594 | $579,493 | |||||||||||
| Cost of sales | 340,114 | 286,722 | 315,289 | |||||||||||
| Gross profit | 295,090 | 230,872 | 264,204 | |||||||||||
| Selling, general and administrative expenses | 77,366 | 68,170 | 71,032 | |||||||||||
| Engineering, research and development expenses | 45,940 | 37,558 | 41,972 | |||||||||||
| Amortization of intangible assets | 12,240 | 11,916 | 11,843 | |||||||||||
| Operating income | 159,544 | 113,228 | 139,357 | |||||||||||
| Interest expense, net | 9,434 | 12,133 | 9,339 | |||||||||||
| Other expense (income), net | 1,888 | (5,305) | 1,917 | |||||||||||
| Income before income tax expense | 148,222 | 106,400 | 128,101 | |||||||||||
| Income tax expense | 30,003 | 19,776 | 10,640 | |||||||||||
| Net income | $118,219 | $86,624 | $117,461 | |||||||||||
| Basic earnings per common share: | $0.87 | $0.64 | $0.87 | |||||||||||
| Diluted earnings per common share: | $0.87 | $0.63 | $0.86 | |||||||||||
| Weighted average shares outstanding: | ||||||||||||||
| Basic | 135,495 | 134,945 | 135,583 | |||||||||||
| Diluted | 136,629 | 136,438 | 136,631 | |||||||||||
| Twelve months ended | |||||||||||
| December 31, 2021 | December 31, 2020 | ||||||||||
| Net sales | $2,298,893 | $1,859,313 | |||||||||
| Cost of sales | 1,239,229 | 1,009,591 | |||||||||
| Gross profit | 1,059,664 | 849,722 | |||||||||
| Selling, general and administrative expenses | 292,408 | 265,128 | |||||||||
| Engineering, research and development expenses | 167,632 | 136,057 | |||||||||
| Amortization of intangible assets | 47,856 | 53,092 | |||||||||
| Operating income | 551,768 | 395,445 | |||||||||
| Interest expense, net | 40,997 | 47,814 | |||||||||
| Other expense (income), net | 31,695 | (6,656) | |||||||||
| Income before income tax expense | 479,076 | 354,287 | |||||||||
| Income tax expense | 69,950 | 59,318 | |||||||||
| Net income | $409,126 | $294,969 | |||||||||
| Basic earnings per common share: | $3.02 | $2.19 | |||||||||
| Diluted earnings per common share: | $3.00 | $2.16 | |||||||||
| Weighted average shares outstanding: | |||||||||||
| Basic | 135,411 | 134,837 | |||||||||
| Diluted | 136,574 | 136,266 | |||||||||
| December 31, 2021 | December 31, 2020 | ||||||||||||||||
| ASSETS | |||||||||||||||||
| Current assets: | |||||||||||||||||
| Cash and cash equivalents | $402,565 | $580,893 | |||||||||||||||
| Trade accounts and notes receivable, net | 347,413 | 264,392 | |||||||||||||||
| Inventories, net | 475,213 | 323,944 | |||||||||||||||
| Deferred tax charges and refundable income taxes | 35,312 | 21,136 | |||||||||||||||
| Other current assets | 52,867 | 43,892 | |||||||||||||||
| Total current assets | 1,313,370 | 1,234,257 | |||||||||||||||
| Property, plant and equipment, net | 654,098 | 525,367 | |||||||||||||||
| Other assets: | |||||||||||||||||
| Right-of-use assets | 66,563 | 45,924 | |||||||||||||||
| Goodwill | 793,702 | 748,037 | |||||||||||||||
| Intangible assets, net | 335,113 | 337,632 | |||||||||||||||
| Deferred tax assets and other noncurrent tax assets | 17,671 | 14,519 | |||||||||||||||
| Other | 11,379 | 11,960 | |||||||||||||||
| Total assets | $3,191,896 | $2,917,696 | |||||||||||||||
| LIABILITIES AND EQUITY | |||||||||||||||||
| Current liabilities | |||||||||||||||||
| Accounts payable | $130,734 | $81,618 | |||||||||||||||
| Accrued liabilities | 199,131 | 177,012 | |||||||||||||||
| Income tax payable | 49,136 | 43,996 | |||||||||||||||
| Total current liabilities | 379,001 | 302,626 | |||||||||||||||
| Long-term debt, excluding current maturities | 937,027 | 1,085,783 | |||||||||||||||
| Long-term lease liability | 60,101 | 39,730 | |||||||||||||||
| Other liabilities | 101,986 | 110,063 | |||||||||||||||
| Shareholders’ equity | 1,713,781 | 1,379,494 | |||||||||||||||
| Total liabilities and equity | $3,191,896 | $2,917,696 | |||||||||||||||
| Three months ended | Twelve months ended | |||||||||||||
| December 31, 2021 | December 31, 2020 | December 31, 2021 | December 31, 2020 | |||||||||||
| Operating activities: | ||||||||||||||
| Net income | $118,219 | $86,624 | $409,126 | $294,969 | ||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||
| Depreciation | 22,801 | 21,366 | 90,311 | 83,430 | ||||||||||
| Amortization | 12,240 | 11,916 | 47,856 | 53,092 | ||||||||||
| Stock-based compensation expense | 7,760 | 6,368 | 29,884 | 22,920 | ||||||||||
| Loss on extinguishment of debt and modification | — | 2,378 | 23,338 | 2,378 | ||||||||||
| Other | (1,354) | (23,878) | (3,330) | 9,227 | ||||||||||
| Changes in operating assets and liabilities, net of effects of acquisitions: | ||||||||||||||
| Trade accounts and notes receivable | (33,408) | 37,906 | (86,766) | (27,461) | ||||||||||
| Inventories | (53,185) | 3,506 | (168,372) | (50,772) | ||||||||||
| Accounts payable and accrued liabilities | 16,000 | 30,086 | 53,577 | 40,162 | ||||||||||
| Income taxes payable, refundable income taxes and noncurrent taxes payable | 31,983 | 40,485 | (3,292) | 28,490 | ||||||||||
| Other | (5,076) | (12,739) | 8,122 | (9,761) | ||||||||||
| Net cash provided by operating activities | 115,980 | 204,018 | 400,454 | 446,674 | ||||||||||
| Investing activities: | ||||||||||||||
| Acquisition of property and equipment | (76,640) | (52,192) | (210,626) | (131,752) | ||||||||||
| Acquisition of business, net of cash acquired | (89,692) | (767) | (91,942) | (111,912) | ||||||||||
| Other | 34 | 73 | 4,450 | 338 | ||||||||||
| Net cash used in investing activities | (166,298) | (52,886) | (298,118) | (243,326) | ||||||||||
| Financing activities: | ||||||||||||||
| Proceeds from revolving credit facility and long-term debt | 50,000 | — | 501,000 | 617,000 | ||||||||||
| Payments of revolving credit facility and long-term debt | (50,000) | — | (651,000) | (468,000) | ||||||||||
| Payments for debt extinguishment costs | — | — | (19,080) | — | ||||||||||
| Payments for dividends | (10,895) | (10,799) | (43,545) | (43,245) | ||||||||||
| Issuance of common stock | 6,872 | 3,839 | 24,744 | 8,738 | ||||||||||
| Taxes paid related to net share settlement of equity awards | (722) | (244) | (16,090) | (24,800) | ||||||||||
| Repurchase and retirement of common stock | (17,109) | (14,999) | (67,109) | (44,563) | ||||||||||
| Deferred acquisition payments | — | — | — | (16,125) | ||||||||||
| Other | (130) | — | (5,417) | (6,856) | ||||||||||
| Net cash (used in) provided by financing activities | (21,984) | (22,203) | (276,497) | 22,149 | ||||||||||
| Effect of exchange rate changes on cash and cash equivalents | (885) | 3,992 | (4,167) | 3,485 | ||||||||||
| (Decrease) increase in cash and cash equivalents | (73,187) | 132,921 | (178,328) | 228,982 | ||||||||||
| Cash and cash equivalents at beginning of period | 475,752 | 447,972 | 580,893 | 351,911 | ||||||||||
| Cash and cash equivalents at end of period | $402,565 | $580,893 | $402,565 | $580,893 | ||||||||||
| Three months ended | Twelve months ended | |||||||||||||||||||
| Net sales | December 31, 2021 | December 31, 2020 | October 2, 2021 | December 31, 2021 | December 31, 2020 | |||||||||||||||
| Specialty Chemicals and Engineered Materials | $188,004 | $168,625 | $176,380 | $711,291 | $609,532 | |||||||||||||||
| Microcontamination Control | 258,866 | 205,626 | 225,877 | 919,363 | 742,186 | |||||||||||||||
| Advanced Materials Handling | 197,703 | 151,741 | 186,200 | 704,946 | 538,682 | |||||||||||||||
| Inter-segment elimination | (9,369) | (8,398) | (8,964) | (36,707) | (31,087) | |||||||||||||||
| Total net sales | $635,204 | $517,594 | $579,493 | $2,298,893 | $1,859,313 | |||||||||||||||
| Three months ended | Twelve months ended | |||||||||||||||||||
| Segment profit | December 31, 2021 | December 31, 2020 | October 2, 2021 | December 31, 2021 | December 31, 2020 | |||||||||||||||
| Specialty Chemicals and Engineered Materials | $47,215 | $29,761 | $41,091 | $167,807 | $127,969 | |||||||||||||||
| Microcontamination Control | 94,203 | 71,691 | 78,399 | 321,300 | 248,910 | |||||||||||||||
| Advanced Materials Handling | 45,304 | 34,321 | 40,503 | 159,995 | 111,028 | |||||||||||||||
| Total segment profit | 186,722 | 135,773 | 159,993 | 649,102 | 487,907 | |||||||||||||||
| Amortization of intangibles | 12,240 | 11,916 | 11,843 | 47,856 | 53,092 | |||||||||||||||
| Unallocated expenses | 14,938 | 10,629 | 8,793 | 49,478 | 39,370 | |||||||||||||||
| Total operating income | $159,544 | $113,228 | $139,357 | $551,768 | $395,445 | |||||||||||||||
| Three months ended | Twelve months ended | |||||||||||||||||||
| December 31, 2021 | December 31, 2020 | October 2, 2021 | December 31, 2021 | December 31, 2020 | ||||||||||||||||
| Net sales | $635,204 | $517,594 | $579,493 | $2,298,893 | $1,859,313 | |||||||||||||||
| Gross profit-GAAP | $295,090 | $230,872 | $264,204 | $1,059,664 | $849,722 | |||||||||||||||
| Adjustments to gross profit: | ||||||||||||||||||||
| Integration costs | — | — | — | — | (1,557) | |||||||||||||||
| Severance and restructuring costs | — | — | — | — | 465 | |||||||||||||||
| Charge for fair value mark-up of acquired inventory sold | 428 | — | — | 428 | 590 | |||||||||||||||
| Adjusted gross profit | $295,518 | $230,872 | $264,204 | $1,060,092 | $849,220 | |||||||||||||||
| Gross margin - as a % of net sales | 46.5 | % | 44.6 | % | 45.6 | % | 46.1 | % | 45.7 | % | ||||||||||
| Adjusted gross margin - as a % of net sales | 46.5 | % | 44.6 | % | 45.6 | % | 46.1 | % | 45.7 | % | ||||||||||
| Three months ended | Twelve months ended | |||||||||||||||||||
| Segment profit-GAAP | December 31, 2021 | December 31, 2020 | October 2, 2021 | December 31, 2021 | December 31, 2020 | |||||||||||||||
| Specialty Chemicals and Engineered Materials (SCEM) | $47,215 | $29,761 | $41,091 | $167,807 | $127,969 | |||||||||||||||
| Microcontamination Control (MC) | 94,203 | 71,691 | 78,399 | 321,300 | 248,910 | |||||||||||||||
| Advanced Materials Handling (AMH) | 45,304 | 34,321 | 40,503 | 159,995 | 111,028 | |||||||||||||||
| Total segment profit | 186,722 | 135,773 | 159,993 | 649,102 | 487,907 | |||||||||||||||
| Amortization of intangible assets | 12,240 | 11,916 | 11,843 | 47,856 | 53,092 | |||||||||||||||
| Unallocated expenses | 14,938 | 10,629 | 8,793 | 49,478 | 39,370 | |||||||||||||||
| Total operating income | $159,544 | $113,228 | $139,357 | $551,768 | $395,445 | |||||||||||||||
| Three months ended | Twelve months ended | |||||||||||||||||||
| Adjusted segment profit | December 31, 2021 | December 31, 2020 | October 2, 2021 | December 31, 2021 | December 31, 2020 | |||||||||||||||
| SCEM segment profit | $47,215 | $29,761 | $41,091 | $167,807 | $127,969 | |||||||||||||||
| Integration costs | — | — | — | — | (1,557) | |||||||||||||||
| Severance and restructuring costs | — | 155 | 69 | 167 | 1,061 | |||||||||||||||
| Charge for fair value write-up of acquired inventory sold | 428 | — | — | 428 | 235 | |||||||||||||||
| SCEM adjusted segment profit | $47,643 | $29,916 | $41,160 | $168,402 | $127,708 | |||||||||||||||
| MC segment profit | $94,203 | $71,691 | $78,399 | $321,300 | $248,910 | |||||||||||||||
| Severance and restructuring costs | — | 167 | 75 | 181 | 1,152 | |||||||||||||||
| Charge for fair value write-up of acquired inventory sold | — | — | — | — | 126 | |||||||||||||||
| MC adjusted segment profit | $94,203 | $71,858 | $78,474 | $321,481 | $250,188 | |||||||||||||||
| AMH segment profit | $45,304 | $34,321 | $40,503 | $159,995 | $111,028 | |||||||||||||||
| Severance and restructuring costs | — | 121 | 52 | 127 | 1,283 | |||||||||||||||
| Charge for fair value write-up of acquired inventory sold | — | — | — | — | 229 | |||||||||||||||
| AMH adjusted segment profit | $45,304 | $34,442 | $40,555 | $160,122 | $112,540 | |||||||||||||||
| Unallocated general and administrative expenses | $14,938 | $10,629 | $8,793 | $49,478 | $39,370 | |||||||||||||||
| Unallocated deal and integration costs | (4,558) | (1,300) | (1,290) | (8,524) | (7,096) | |||||||||||||||
| Unallocated severance and restructuring costs | — | (58) | (10) | (54) | (868) | |||||||||||||||
| Adjusted unallocated general and administrative expenses | $10,380 | $9,271 | $7,493 | $40,900 | $31,406 | |||||||||||||||
| Total adjusted segment profit | $187,150 | $136,216 | $160,189 | $650,005 | $490,436 | |||||||||||||||
| Adjusted amortization of intangible assets | — | — | — | — | — | |||||||||||||||
| Adjusted unallocated general and administrative expenses | 10,380 | 9,271 | 7,493 | 40,900 | 31,406 | |||||||||||||||
| Total adjusted operating income | $176,770 | $126,945 | $152,696 | $609,105 | $459,030 | |||||||||||||||
| Three months ended | Twelve months ended | |||||||||||||||||||
| December 31, 2021 | December 31, 2020 | October 2, 2021 | December 31, 2021 | December 31, 2020 | ||||||||||||||||
| Net sales | $635,204 | $517,594 | $579,493 | $2,298,893 | $1,859,313 | |||||||||||||||
| Net income | $118,219 | $86,624 | $117,461 | $409,126 | $294,969 | |||||||||||||||
| Net income - as a % of net sales | 18.6 | % | 16.7 | % | 20.3 | % | 17.8 | % | 15.9 | % | ||||||||||
| Adjustments to net income: | ||||||||||||||||||||
| Income tax expense | 30,003 | 19,776 | 10,640 | 69,950 | 59,318 | |||||||||||||||
| Interest expense, net | 9,434 | 12,133 | 9,339 | 40,997 | 47,814 | |||||||||||||||
| Other expense (income), net | 1,888 | (5,305) | 1,917 | 31,695 | (6,656) | |||||||||||||||
| GAAP - Operating income | 159,544 | 113,228 | 139,357 | 551,768 | 395,445 | |||||||||||||||
| Operating margin - as a % of net sales | 25.1 | % | 21.9 | % | 24.0 | % | 24.0 | % | 21.3 | % | ||||||||||
| Charge for fair value write-up of acquired inventory sold | 428 | — | — | 428 | 590 | |||||||||||||||
| Deal and transaction costs | 4,744 | — | — | 4,744 | 2,576 | |||||||||||||||
| Integration costs | (186) | 1,300 | 1,290 | 3,780 | 2,963 | |||||||||||||||
| Severance and restructuring costs | — | 501 | 206 | 529 | 4,364 | |||||||||||||||
| Amortization of intangible assets | 12,240 | 11,916 | 11,843 | 47,856 | 53,092 | |||||||||||||||
| Adjusted operating income | 176,770 | 126,945 | 152,696 | 609,105 | 459,030 | |||||||||||||||
| Adjusted operating margin - as a % of net sales | 27.8 | % | 24.5 | % | 26.3 | % | 26.5 | % | 24.7 | % | ||||||||||
| Depreciation | 22,801 | 21,366 | 22,841 | 90,311 | 83,430 | |||||||||||||||
| Adjusted EBITDA | $199,571 | $148,311 | $175,537 | $699,416 | $542,460 | |||||||||||||||
| Adjusted EBITDA - as a % of net sales | 31.4 | % | 28.7 | % | 30.3 | % | 30.4 | % | 29.2 | % | ||||||||||
| Three months ended | Twelve months ended | |||||||||||||||||||
| December 31, 2021 | December 31, 2020 | October 2, 2021 | December 31, 2021 | December 31, 2020 | ||||||||||||||||
| GAAP net income | $118,219 | $86,624 | $117,461 | $409,126 | $294,969 | |||||||||||||||
| Adjustments to net income: | ||||||||||||||||||||
| Charge for fair value write-up of inventory acquired | 428 | — | — | 428 | 590 | |||||||||||||||
| Deal and transaction costs | 4,744 | — | — | 4,744 | 2,576 | |||||||||||||||
| Integration costs | (186) | 1,300 | 1,290 | 3,780 | 2,963 | |||||||||||||||
| Severance and restructuring costs | — | 501 | 206 | 529 | 4,364 | |||||||||||||||
| Loss on extinguishment of debt and modification | — | — | — | 23,338 | 2,378 | |||||||||||||||
| Amortization of intangible assets | 12,240 | 11,916 | 11,843 | 47,856 | 53,092 | |||||||||||||||
Tax effect of adjustments to net income and discrete items1 | (3,662) | (3,218) | (5,417) | (20,411) | (15,197) | |||||||||||||||
| Non-GAAP net income | $131,783 | $97,123 | $125,383 | $469,390 | $345,735 | |||||||||||||||
| Diluted earnings per common share | $0.87 | $0.63 | $0.86 | $3.00 | $2.16 | |||||||||||||||
| Effect of adjustments to net income | $0.10 | $0.08 | $0.06 | $0.44 | $0.37 | |||||||||||||||
| Diluted non-GAAP earnings per common share | $0.96 | $0.71 | $0.92 | $3.44 | $2.54 | |||||||||||||||
| First-Quarter Outlook | |||||
| Reconciliation GAAP net income to non-GAAP net income | April 2, 2022 | ||||
| GAAP net income | $111 - $118 | ||||
| Adjustments to net income: | |||||
| Restructuring and integration costs | 12 | ||||
| Amortization of intangible assets | 12 | ||||
| Income tax effect | (4) | ||||
| Non-GAAP net income | $131 - $138 | ||||
| First-Quarter Outlook | |||||
| Reconciliation GAAP diluted earnings per share to non-GAAP diluted earnings per share | April 2, 2022 | ||||
| Diluted earnings per common share | $0.81 - $0.86 | ||||
| Adjustments to diluted earnings per common share: | |||||
| Restructuring and integration costs | 0.09 | ||||
| Amortization of intangible assets | 0.09 | ||||
| Income tax effect | (0.03) | ||||
| Diluted non-GAAP earnings per common share | $0.96 - $1.01 | ||||